Twist Bioscience Corporation has announced the appointment of Trynka Shineman Blake to its board of directors. She will also serve on the audit committee. Ms. Shineman Blake, who previously served as CEO of Vistaprint, brings extensive experience in corporate governance, customer experience, and digital transformation. Her appointment is expected to contribute to Twist Bioscience's strategic direction and growth as the company works towards achieving adjusted EBITDA breakeven and delivering innovative solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250806218674) on August 06, 2025, and is solely responsible for the information contained therein.